China National Accord Medicines Corporation Ltd.

Shenzhen Stock Exchange 000028.SZ

China National Accord Medicines Corporation Ltd. Goodwill for the year ending December 31, 2023: USD 386.87 M

China National Accord Medicines Corporation Ltd. Goodwill is USD 386.87 M for the year ending December 31, 2023, a -2.92% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
  • China National Accord Medicines Corporation Ltd. Goodwill for the year ending December 31, 2022 was USD 398.49 M, a -8.78% change year over year.
  • China National Accord Medicines Corporation Ltd. Goodwill for the year ending December 31, 2021 was USD 436.83 M, a 3.79% change year over year.
  • China National Accord Medicines Corporation Ltd. Goodwill for the year ending December 31, 2020 was USD 420.90 M, a 210.47% change year over year.
  • China National Accord Medicines Corporation Ltd. Goodwill for the year ending December 31, 2019 was USD 135.57 M, a 11.86% change year over year.
Key data
Date Goodwill Total Assets Current Liabilities Total Non-Current Liabilities
Market news
Loading...
Shenzhen Stock Exchange: 000028.SZ

China National Accord Medicines Corporation Ltd.

CEO Mr. Zhaoxiong Lin MBA
IPO Date June 8, 1993
Location China
Headquarters Accord Pharm. Building
Employees 39,449
Sector Health Care
Industries
Description

China National Accord Medicines Corporation Ltd. engages in the distribution of medicine and pharmaceutical products. The company sells Chinese traditional, bio-chemical, biological, and diagnosis medicines, as well as antibiotics; chemical preparations; food products; chemical products; and various commodities. It also engages in the sale of medical apparatus and instruments; provision of freight transportation, storage, loading and unloading, and professional consultation services; provision of glass wares, cosmetics, and daily merchandise, as well as goods agency services; import and export of technology; leasing of house properties; and wholesale and retail of health products. As of December 31, 2021, the company operated a network of 8,798 drugstores, including 7,257 directly owned stores and 1,541 franchised stores covering 20 provinces, autonomous regions, and municipalities in China. The company was founded in 2004 and is based in Shenzhen, China. China National Accord Medicines Corporation Ltd. is a subsidiary of Sinopharm Group Co., Ltd.

StockViz Staff

January 15, 2025

Any question? Send us an email